Selected article for: "accelerated lung function decline and lung function"

Author: Ritchie, Andrew I.; Wedzicha, Jadwiga A.
Title: Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations
  • Cord-id: xnos7iud
  • Document date: 2020_8_12
  • ID: xnos7iud
    Snippet: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are episodes of symptom worsening which have significant adverse consequences for patients. Exacerbations are highly heterogeneous events associated with increased airway and systemic inflammation and physiological changes. The frequency of exacerbations is associated with accelerated lung function decline, quality of life impairment and increased mortality. They are triggered predominantly by respiratory viruses and bacteria,
    Document: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are episodes of symptom worsening which have significant adverse consequences for patients. Exacerbations are highly heterogeneous events associated with increased airway and systemic inflammation and physiological changes. The frequency of exacerbations is associated with accelerated lung function decline, quality of life impairment and increased mortality. They are triggered predominantly by respiratory viruses and bacteria, which infect the lower airway and increase airway inflammation. A proportion of patients appear to be more susceptible to exacerbations, with poorer quality of life and more aggressive disease progression than those who have infrequent exacerbations. Exacerbations also contribute significantly to healthcare expenditure. Prevention and mitigation of exacerbations are therefore key goals of COPD management.

    Search related documents:
    Co phrase search for related documents
    • acute exacerbation and adhesion molecule: 1
    • acute exacerbation and long term maintenance therapy: 1
    • acute exacerbation and longitudinal study: 1, 2, 3, 4
    • acute exacerbation and low respiratory: 1
    • acute exacerbation and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
    • acute exacerbation and lung function decline: 1, 2
    • acute exacerbation and lung inflammation: 1, 2, 3, 4, 5
    • acute exacerbation and lung microbiome: 1, 2, 3, 4, 5
    • acute exacerbation and macrophages alveolar: 1
    • acute treatment and additional therapy: 1, 2, 3, 4, 5, 6, 7
    • acute treatment and long hospital: 1, 2, 3, 4, 5
    • acute treatment and long hospital stay: 1
    • acute treatment and long term maintenance therapy: 1
    • acute treatment and longitudinal study: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute treatment and low number: 1
    • acute treatment and low respiratory: 1, 2
    • acute treatment and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute treatment and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
    • acute treatment and lung microbiome: 1